Zuercher, Patrick
Moser, André
Garcia de Guadiana-Romualdo, Luis
Llewelyn, Martin J.
Graf, Rolf
Reding, Theresia
Eggimann, Philippe
Que, Yok-Ai
Prazak, Josef
Funding for this research was provided by:
University of Bern
Article History
Received: 28 June 2023
Accepted: 30 August 2023
First Online: 14 September 2023
Declarations
:
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare: no support from any organisation for the submitted work. RG has received research grants from Gebert Rüf Foundation, in addition, Dr. Graf has a patent method for assaying sepsis and outcome in humans by detection of PSP/reg licensed to LASCCO. DS reports grants from Astra-Zeneca AG, Curetis AG, Boston Scientific, other from Astra-Zeneca AG, Novartis AG, GSK AG, Roche AG, Zambon, Pfizer and Schwabe Pharma AG, Vifor AG, outside the submitted work. PE has received research grants from Abionic outside the submitted work.
: The study was registered on Prospero (#CRD42022308207). The Cantonal Ethical Committee of the State of Bern (#2018-01356_V2.1_25.2.2022) reviewed and approved the meta-analysis research protocol while the respective ethical committees already approved all individual studies.
: Not applicable.